The Princess Alexandra Hospital NHS Trust serves a population of 258,000 and provides healthcare services to the communities of Harlow and the surrounding areas.

During the past decade, Princess Alexandra Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Alexandra Hospital" #1 sponsor was "University College, London" with 6 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "DePuy International" with 2 trials sponsored, "DePuy Orthopaedics" with 2 trials sponsored and "Medical Research Council" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Alexandra Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Princess Alexandra Hospital" are "Colorectal Cancer" (4 trials), "Prostate Cancer" (4 trials), "Rheumatoid Arthritis" (3 trials), "Breast Cancer" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Princess Alexandra Hospital" in a lesser frequency.

Most popular intervention types in "Princess Alexandra Hospital" are "Drug" (24 trials), "Radiation" (6 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "capecitabine" (4 trials), "adjuvant therapy" (3 trials), "cisplatin" (3 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Princess Alexandra Hospital" are 31 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Princess Alexandra Hospital". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Princess Alexandra Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Alexandra Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Princess Alexandra Hospital has several departments that took part in Clinical trials: "Princess Alexandra Hospital; Oncology Department" - 3 trials